在心力衰竭中,左心室基因表达与保存的喷射小部分-前纤维细胞和前炎性通路和基因
Bo Ye1, Amy D Bradshaw2, Juan E Abrahante1
1Lillehei Heart Institute and Genomics Center of the University of Minnesota, Minneapolis (B.Y., J.E.A., M.M.).
Circulation. Heart failure
|August 15, 2023
概括
保存喷射分数 (HFpEF) 的心力衰竭涉及显著的心脏纤维化. 对HFpEF患者的转录组分析显示,细胞外基因表达增加是纤维化的主要驱动因素,而不是炎症.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭是一个日益增长的临床挑战,治疗选择有限.
- 驱动HFpEF病原体的精确分子机制尚不清楚.
- 预发炎性途径被假设在HFpEF中导致心脏纤维化.
研究的目的:
- 通过比较患者和对照心肌组织中的基因表达特征来研究HFpEF的分子基础.
- 评估亲炎性和亲纤维性信号通路在HFpEF发展中的作用.
主要方法:
- 从HFpEF患者获得心脏左心室活检,并在冠状动脉旁路手术期间匹配对照.
- 在快速结的心肌组织上进行RNA测序,以生成全面的左心室转录组.
- 无监督分析比较了HFpEF和对照组之间的基因表达模式.
主要成果:
- 与对照组相比,HFpEF患者表现出不同的人口和临床特征,包括高血压,更高的BMI和较高的NT-proBNP水平.
- 转录组分析在HFpEF中发现了477个差异表达的基因.
- 这些基因主要与益菌性通路有关,特别是细胞外基质生产和翻译后修饰,没有证据表明有炎症特征.
结论:
- 在HFpEF左心室肌肉中的基因表达特征证实了显著的细胞外矩阵基因上调,表明心肌纤维化.
- 与假设相反,在研究的HFpEF队列中,激活的促炎途径没有被确定为关键特征.
- 这些发现突出显示了HFpEF病理生理学的核心,与炎症过程不同的是益纤维化机制.
相关概念视频
01:29Heart Failure II: Pathophysiology
15
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
01:30Heart Failure V: Medical Management
13
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13
01:27Heart Failure I: Introduction
16
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
16